CompletedNot Applicable

CBM in the Context of Exposure for Acrophobia

Germany81 participantsStarted 2023-04-11

Plain-language summary

The proposed study will apply a one-session exposure treatment combined with CBM training modifying interpretational processing biases versus a sham training in acrophobic individuals. The main aim is to advance our understanding of the mechanisms underlying exposure treatment.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Informed consent
✓. Sufficient German language skills to complete the experimental tasks and questionnaires
✓. Aged between 18 and 65 years
✓. Current primary diagnosis of acrophobia as defined by DSM-5 (based on DIPS)
✓. Lives within reasonable travelling distance of the research center

Exclusion criteria

✕. Currently in psychotherapeutic treatment
✕. Impaired therapy capability (as judged by researcher/clinician)
✕. Current diagnosis of substance use disorder (via DIPS)
✕. Current or past diagnosis of psychotic disorder or bipolar disorder (via DIPS)
✕. Acute suicidality (via DIPS)
✕. Diagnosis of chronical physical or neurological diseases (self-reported by participant)
✕. Personality Disorder (via DIPS or via clinical judgement)
✕. Attention-deficit hyperactivity disorder (self-reported by participant or via DIPS)

What they're measuring

Acrophobia-related interpretational processing biases as measured using the Encoding Recognition Task

Timeframe: baseline, post-training (~1 week post-baseline)

Trial details

NCT IDNCT05780203

SponsorRuhr University of Bochum

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-10-27

View on ClinicalTrials.gov More Acrophobia trials